Skip to main content
Tinavi Medical Technologies Co.,Ltd. logo

Tinavi Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688277 ISIN · CNE100004256 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 760 across all filing types
Latest filing 2025-04-08 Share Issue/Capital Cha…
Country CN China
Listing Shanghai Stock Exchange 688277

About Tinavi Medical Technologies Co.,Ltd.

https://www.tinavi.com/

Tinavi Medical Technologies Co.,Ltd. specializes in the design, development, and commercialization of orthopedic surgical robotic systems. Its primary offering, the TiRobot system, provides a multi-functional platform for spine and trauma surgeries, supporting procedures such as pedicle screw fixation and pelvic fracture reduction. The technology incorporates high-definition 3D imaging, precise mechanical arms, and advanced navigation software to facilitate minimally invasive operations with sub-millimeter accuracy. By integrating preoperative planning with real-time intraoperative guidance, the system aims to enhance surgical precision, reduce recovery times, and minimize radiation exposure for clinical teams. The company focuses on delivering intelligent robotic solutions to hospitals and specialized surgical centers to improve the consistency and safety of complex orthopedic interventions.

Recent filings

Filing Released Lang Actions
2023年限制性股票激励计划首次及预留授予部分第一个归属期归属结果暨股份上市公告
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement from Beijing Tianzhihang Medical Technology Co., Ltd. regarding the first vesting period results and listing of shares under the 2023 restricted stock incentive plan. It details the decision-making process, the number of shares vested, the listing date, shareholding changes, and the impact on recent financial reports. The document includes specific dates, share quantities, and references to regulatory approvals and stock registration. It is not a full financial report but an announcement about stock incentive plan share vesting and listing. The document length is 4422 characters, which is relatively short but contains detailed information about share issuance and listing related to the stock incentive plan. This fits best under the category of Share Issue/Capital Change (SHA), as it announces new shares issued under a stock incentive plan and their listing. It is not a report publication announcement or a regulatory filing fallback because it contains substantive details about the share issuance and listing event itself.
2025-04-08 Chinese
北京市康达律师事务所关于北京天智航医疗科技股份有限公司2025年第一次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality of the convening and procedures of the 2025 first extraordinary general meeting (临时股东大会) of Beijing Tianzhihang Medical Technology Co., Ltd. It details the meeting's convening, attendance, voting procedures, and results. The document does not contain financial statements or financial performance data but focuses on the legal validation of the shareholders' meeting process and voting outcomes. This type of document is not an Annual Report, Interim Report, Earnings Release, or any financial report. It is also not a simple announcement of a meeting or voting results but a legal opinion on the meeting's legality. Given the content and nature, this fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it includes detailed voting results and legal validation of the meeting and voting process. The document length is 4001 characters, which is relatively short but contains substantive content about voting results and legal opinions, not just an announcement or notice. Therefore, the most appropriate classification is DVA with high confidence.
2025-04-02 Chinese
2025年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2025 first extraordinary general meeting of shareholders of Beijing Tianzhihang Medical Technology Co., Ltd. It includes information about the meeting date, location, attendance, voting results, and legal witness statements. The content focuses on the voting outcomes and procedural compliance of the shareholder meeting, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is not a full annual or interim report, nor is it a proxy solicitation or management report. It is also not a brief announcement of a report publication but a substantive disclosure of voting results. Therefore, the appropriate classification is DVA with high confidence.
2025-04-02 Chinese
中信建投证券股份有限公司关于北京天智航医疗科技股份有限公司预计2025年度日常关联交易的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed opinion from a sponsoring securities company regarding the expected related party transactions for the year 2025 of Beijing Tianzhihang Medical Technology Co., Ltd. It includes detailed descriptions of the related party transactions, amounts, approval procedures, related parties' information, and the sponsor's opinion on the fairness and necessity of these transactions. The document references regulatory rules related to securities issuance and listing, and it is a formal verification and opinion report rather than a financial report or earnings release. It does not contain financial statements or quarterly/yearly financial results, nor is it a simple announcement or certification. The content fits best with an Audit Report / Information (AR) category, as it involves audit-related verification and opinions on compliance and transaction fairness, but is not a full annual report or interim report.
2025-03-31 Chinese
第五届监事会第八次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of a supervisory board meeting resolution by Beijing Tianzhihang Medical Technology Co., Ltd. It details the meeting attendance, the approval of a proposal regarding expected related party transactions for the year 2025, and mentions that the proposal will be submitted to the shareholders' meeting. The document is short (740 characters) and serves as a meeting resolution announcement rather than a full report or financial statement. It does not contain financial data, audit information, or detailed management discussion. It is not a report publication announcement since it contains substantive meeting resolution content. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-03-31 Chinese
关于预计2025年度日常关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company's expected daily related-party transactions for the fiscal year 2025. It includes details about the nature, amounts, and parties involved in these related-party transactions, the approval process by the board and independent directors, and the necessity of submitting the matter to the shareholders' meeting for approval. The document is a formal disclosure of anticipated related-party transactions, which is a regulatory announcement rather than a financial report or detailed management discussion. It does not contain financial statements or comprehensive financial analysis but focuses on governance and compliance aspects related to related-party transactions. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements that do not fit other specific categories.
2025-03-31 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.